Pharmaceutical company Allergan has voluntarily recalled its Taytulla oral contraceptive pills in the US following reports of a packaging error.
A physician report has identified that four placebo capsules in the Taytulla packaging were misplaced in the sample pack of the contraceptive pills.
Go deeper with GlobalData
As a result of the packaging error, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules, posing a pregnancy risk.
The company has explained the 28-capsule card should start with 24 active pink softgel capsules, which are to be taken once a day, followed by the four maroon capsules to end the month.
Customers with the scrambled capsule card will get a recall letter from the company, which will arrange for the pills to be returned. The affected lot number is 5620706 with the expiration date of May 2019.
In a statement, Allergan said: “As a result of this packaging error, oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order.”
According to Allergan, the Taytulla softgel capsules 1mg/20mcg sample packs have been in circulation nationwide since 27 August last year.
